Envestnet Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Buy |
44,734
+13,842
| +45% | +$409K | ﹤0.01% | 3097 |
|
2025
Q1 | $922K | Buy |
30,892
+6,554
| +27% | +$196K | ﹤0.01% | 3261 |
|
2024
Q4 | $697K | Buy |
24,338
+152
| +0.6% | +$4.36K | ﹤0.01% | 3391 |
|
2024
Q3 | $935K | Buy |
24,186
+3,692
| +18% | +$143K | ﹤0.01% | 3172 |
|
2024
Q2 | $660K | Buy |
20,494
+3,465
| +20% | +$112K | ﹤0.01% | 3296 |
|
2024
Q1 | $661K | Sell |
17,029
-2,951
| -15% | -$115K | ﹤0.01% | 3276 |
|
2023
Q4 | $615K | Buy |
19,980
+2,020
| +11% | +$62.2K | ﹤0.01% | 3214 |
|
2023
Q3 | $401K | Buy |
17,960
+2,119
| +13% | +$47.4K | ﹤0.01% | 3365 |
|
2023
Q2 | $340K | Sell |
15,841
-1,218
| -7% | -$26.2K | ﹤0.01% | 3422 |
|
2023
Q1 | $409K | Sell |
17,059
-614
| -3% | -$14.7K | ﹤0.01% | 3281 |
|
2022
Q4 | $410K | Sell |
17,673
-28
| -0.2% | -$650 | ﹤0.01% | 3214 |
|
2022
Q3 | $284K | Buy |
17,701
+1,599
| +10% | +$25.7K | ﹤0.01% | 3382 |
|
2022
Q2 | $285K | Buy |
16,102
+74
| +0.5% | +$1.31K | ﹤0.01% | 3388 |
|
2022
Q1 | $326K | Buy |
16,028
+3,058
| +24% | +$62.2K | ﹤0.01% | 3405 |
|
2021
Q4 | $242K | Sell |
12,970
-4,340
| -25% | -$81K | ﹤0.01% | 3548 |
|
2021
Q3 | $342K | Buy |
17,310
+2,631
| +18% | +$52K | ﹤0.01% | 3214 |
|
2021
Q2 | $347K | Buy |
14,679
+621
| +4% | +$14.7K | ﹤0.01% | 3200 |
|
2021
Q1 | $333K | Sell |
14,058
-258
| -2% | -$6.11K | ﹤0.01% | 3081 |
|
2020
Q4 | $287K | Buy |
14,316
+3,289
| +30% | +$65.9K | ﹤0.01% | 2945 |
|
2020
Q3 | $230K | Buy |
11,027
+173
| +2% | +$3.61K | ﹤0.01% | 2848 |
|
2020
Q2 | $190K | Buy |
10,854
+630
| +6% | +$11K | ﹤0.01% | 2885 |
|
2020
Q1 | $167K | Buy |
+10,224
| New | +$167K | ﹤0.01% | 2767 |
|
2017
Q2 | – | Sell |
-70
| Closed | -$1K | – | 3057 |
|
2017
Q1 | $1K | Hold |
70
| – | – | ﹤0.01% | 3045 |
|
2016
Q4 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 3025 |
|